Clinical relevance of brachial pulse pressure as a measure of cerebrovascular disease risk.
Clinical relevance of brachial pulse pressure as a measure of cerebrovascular disease risk.
复制标题
肱动脉脉压作为脑血管疾病风险衡量指标的临床相关性。
DOI:
10.1111/jch.13582
复制
发表时间:
2019
期刊:
影响因子:
--
通讯作者:
Perdomo,SophyJ
中科院分区:
文献类型:
--
作者:
Perdomo,SophyJ
Pulse pressure (PP), the difference between systolic blood pressure and diastolic blood pressure, is a measure of arterial stiffness. 1 Higher PP is associated with increased cardiovascular morbidity and mortality2 and with cerebrovascular disease outcomes such as stroke, Alzheimer's disease, and cognitive decline. 3-5 Furthermore, higher PP is associated with cerebrovascular pathology such as white matter hyperintensities (WMH). 6-9 WMH are clinically meaningful markers of increased risk of death, stroke, dementia, depression, and loss of mobility. 10 Given the clinical relevance of WMH, it is important to elucidate the underlying mechanisms. To this end, PP is hypothesized to result in WMH via its transmission of increased pulsatile flow into the brain. 1, 7-9, 11, 12 The pulsatile flow created by cardiac contractions is not buffered well by stiffer arteries (indicated by increased PP), and thus, pulsatile flow penetrates into the deep structures of the brain, damaging the microvasculature and surrounding tissue (WMH). 1, 7-9, 11, 12 A number of studies have demonstrated associations between PP, pulsatile flow, and WMH. For instance, higher aortic and carotid PP are associated with higher cerebral pulsatile flow in the middle cerebral artery and greater WMH. 8, 9 Moreover, increased brachial PP (bPP; over a 3-year period) is associated with higher pulsatile flow in the internal carotid artery and greater WMH. 11 Taken together, these data support the hypothesis that higher PP transmits increased pulsatile flow to the brain, which subsequently results in WMH. In addition to WMH, bPP also appears to play a role in stroke and Alzheimer's disease. A systematic review and meta-analysis concluded that a 10 mm Hg increase in bPP is independently associated with an increased risk in stroke. 3 bPP is also associated with clinical outcomes following stroke, such as 30-day mortality, recurrent stroke, and neurologic deterioration. 3 Moreover, a higher bPP is associated with an increased risk of Alzheimer's disease and dementia4 and with increased tau phosphorylation (Alzheimer's disease biomarker). 13 Furthermore, increased bPP has been found to predict declines in overall cognition, memory, and concentration 11 years later. 5Given the association of higher bPP with cerebrovascular disease risk, bPP could serve as a valuable clinical screening tool for cerebrovascular health. Carotid-femoral pulse wave velocity, the gold standard for arterial stiffness, 14 is primarily used for research and not readily accessible to clinicians or the general population. bPP, conversely, can be measured at any routine clinical visit and is strongly correlated with carotid-femoral pulse wave velocity and central PP (cPP), making it a valid and accessible indicator of aortic stiffness. 1, 2 Additionally, bPP is more strongly correlated with cerebral pulsatile flow compared to cPP, 1 suggesting that bPP may provide a more accurate representation of cerebrovascular health risk. Since bPP is simply calculated from blood pressure, this offers a unique opportunity to use bPP as a proxy for cerebrovascular disease risk at routine physician examinations. Finally, bPP can easily be monitored over time, making it an attractive assessment tool to track cerebrovascular disease risk (“poor brain health”). Thus, further research is warranted on the application of bPP as a proxy for cerebrovascular disease risk.